 Marcelo Sousa
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Outer Membrane Proteins | 13 | 2023 | 58 | 4.500 |
Why?
| | Escherichia coli Proteins | 13 | 2023 | 178 | 4.410 |
Why?
| | Polymyxins | 6 | 2023 | 9 | 2.870 |
Why?
| | Escherichia coli | 10 | 2023 | 774 | 1.780 |
Why?
| | Lipid A | 3 | 2023 | 29 | 1.320 |
Why?
| | Models, Molecular | 19 | 2018 | 1492 | 1.240 |
Why?
| | Protein Conformation | 12 | 2014 | 859 | 1.160 |
Why?
| | Protein Structure, Tertiary | 12 | 2015 | 840 | 1.130 |
Why?
| | Bacterial Proteins | 5 | 2023 | 835 | 1.030 |
Why?
| | Amino Sugars | 4 | 2023 | 7 | 0.930 |
Why?
| | Rhodothermus | 2 | 2015 | 2 | 0.880 |
Why?
| | Crystallography, X-Ray | 12 | 2014 | 436 | 0.850 |
Why?
| | Protein Folding | 9 | 2023 | 266 | 0.830 |
Why?
| | NAD | 1 | 2023 | 75 | 0.810 |
Why?
| | Type III Secretion Systems | 1 | 2021 | 11 | 0.720 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2021 | 57 | 0.690 |
Why?
| | Guanylate Cyclase-Activating Proteins | 3 | 2010 | 6 | 0.630 |
Why?
| | Thermodynamics | 2 | 2021 | 408 | 0.620 |
Why?
| | Drug Resistance, Bacterial | 2 | 2014 | 176 | 0.620 |
Why?
| | Scattering, Small Angle | 2 | 2015 | 20 | 0.560 |
Why?
| | Protein Structure, Secondary | 6 | 2016 | 341 | 0.560 |
Why?
| | Aldose-Ketose Isomerases | 2 | 2013 | 7 | 0.510 |
Why?
| | Molecular Chaperones | 2 | 2009 | 182 | 0.480 |
Why?
| | Gram-Negative Bacteria | 2 | 2021 | 70 | 0.480 |
Why?
| | Carboxy-Lyases | 2 | 2005 | 8 | 0.480 |
Why?
| | Drug Resistance, Microbial | 2 | 2005 | 69 | 0.470 |
Why?
| | Calcium | 4 | 2010 | 1213 | 0.460 |
Why?
| | X-Ray Diffraction | 1 | 2015 | 94 | 0.460 |
Why?
| | Transaminases | 1 | 2014 | 23 | 0.440 |
Why?
| | Anti-Bacterial Agents | 3 | 2023 | 1717 | 0.440 |
Why?
| | Binding Sites | 7 | 2015 | 1252 | 0.430 |
Why?
| | Amino Acid Sequence | 9 | 2014 | 2058 | 0.400 |
Why?
| | Salmonella typhimurium | 1 | 2014 | 175 | 0.390 |
Why?
| | Periplasmic Proteins | 1 | 2010 | 4 | 0.360 |
Why?
| | Molecular Sequence Data | 9 | 2013 | 2832 | 0.350 |
Why?
| | Vision, Ocular | 2 | 2008 | 35 | 0.340 |
Why?
| | Protein Binding | 7 | 2016 | 2121 | 0.340 |
Why?
| | Uridine Diphosphate Glucuronic Acid | 3 | 2023 | 3 | 0.330 |
Why?
| | Substrate Specificity | 5 | 2014 | 368 | 0.330 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 347 | 0.330 |
Why?
| | Periplasm | 3 | 2016 | 11 | 0.330 |
Why?
| | Microscopy, Atomic Force | 3 | 2021 | 116 | 0.320 |
Why?
| | DNA-Binding Proteins | 2 | 2009 | 1443 | 0.320 |
Why?
| | Retinal Diseases | 2 | 2008 | 88 | 0.310 |
Why?
| | Avian Proteins | 1 | 2007 | 21 | 0.290 |
Why?
| | Cell Membrane | 2 | 2023 | 732 | 0.260 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2006 | 16 | 0.260 |
Why?
| | Mutation | 5 | 2016 | 3717 | 0.250 |
Why?
| | Uridine Diphosphate Glucose Dehydrogenase | 1 | 2005 | 1 | 0.250 |
Why?
| | Catalytic Domain | 3 | 2014 | 218 | 0.250 |
Why?
| | Uronic Acids | 1 | 2025 | 1 | 0.240 |
Why?
| | Diphosphates | 1 | 2025 | 17 | 0.240 |
Why?
| | Ligands | 2 | 2023 | 622 | 0.230 |
Why?
| | Nucleotides | 1 | 2025 | 122 | 0.220 |
Why?
| | Phosphatidate Phosphatase | 1 | 2023 | 5 | 0.220 |
Why?
| | SEC Translocation Channels | 1 | 2023 | 10 | 0.220 |
Why?
| | Arabinose | 1 | 2023 | 4 | 0.220 |
Why?
| | Carbohydrates | 1 | 2023 | 64 | 0.210 |
Why?
| | Molecular Dynamics Simulation | 4 | 2018 | 217 | 0.200 |
Why?
| | Oxidoreductases | 1 | 2023 | 92 | 0.200 |
Why?
| | Serine Endopeptidases | 1 | 2002 | 118 | 0.180 |
Why?
| | Heat-Shock Proteins | 1 | 2002 | 136 | 0.180 |
Why?
| | Protein Domains | 3 | 2018 | 253 | 0.180 |
Why?
| | Salmonella | 1 | 2021 | 59 | 0.170 |
Why?
| | Protein Stability | 1 | 2021 | 162 | 0.170 |
Why?
| | Hydrogen Bonding | 2 | 2014 | 149 | 0.170 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 372 | 0.160 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 257 | 0.150 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2018 | 45 | 0.150 |
Why?
| | Guanylate Cyclase | 2 | 2008 | 35 | 0.140 |
Why?
| | Cyclic GMP | 2 | 2008 | 90 | 0.140 |
Why?
| | Base Sequence | 2 | 2014 | 2142 | 0.130 |
Why?
| | Crystallization | 2 | 2008 | 138 | 0.130 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1304 | 0.130 |
Why?
| | Liposomes | 1 | 2017 | 168 | 0.130 |
Why?
| | Amino Acid Motifs | 2 | 2014 | 213 | 0.120 |
Why?
| | Ionic Liquids | 1 | 2015 | 7 | 0.120 |
Why?
| | Hydroxymethyl and Formyl Transferases | 2 | 2005 | 2 | 0.120 |
Why?
| | Spectrum Analysis | 1 | 2015 | 89 | 0.120 |
Why?
| | Cations | 1 | 2014 | 80 | 0.110 |
Why?
| | Quality Control | 1 | 2015 | 163 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2014 | 38 | 0.110 |
Why?
| | Melanoma | 2 | 2013 | 730 | 0.110 |
Why?
| | Escherichia coli O157 | 1 | 2014 | 31 | 0.110 |
Why?
| | Imidazoles | 1 | 2015 | 234 | 0.110 |
Why?
| | Solubility | 1 | 2015 | 235 | 0.110 |
Why?
| | Uridine Diphosphate Sugars | 1 | 2014 | 2 | 0.110 |
Why?
| | Neoplasm Invasiveness | 2 | 2013 | 485 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 116 | 0.110 |
Why?
| | Protein Interaction Mapping | 1 | 2014 | 108 | 0.110 |
Why?
| | Pyridoxal Phosphate | 1 | 2014 | 21 | 0.110 |
Why?
| | Mutagenesis | 1 | 2014 | 181 | 0.110 |
Why?
| | Ribulosephosphates | 1 | 2013 | 2 | 0.110 |
Why?
| | Isomerases | 1 | 2013 | 8 | 0.110 |
Why?
| | Lipoproteins | 1 | 2014 | 171 | 0.110 |
Why?
| | Genetic Complementation Test | 1 | 2013 | 63 | 0.110 |
Why?
| | Kinetics | 1 | 2017 | 1642 | 0.110 |
Why?
| | Multienzyme Complexes | 2 | 2004 | 68 | 0.110 |
Why?
| | Protein Subunits | 1 | 2014 | 235 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 186 | 0.100 |
Why?
| | Arginine | 1 | 2014 | 265 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 643 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 109 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 891 | 0.100 |
Why?
| | Adenosine Triphosphate | 2 | 2005 | 480 | 0.100 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 548 | 0.100 |
Why?
| | Lipid-Linked Proteins | 1 | 2011 | 1 | 0.090 |
Why?
| | Proteins | 1 | 2017 | 942 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 352 | 0.090 |
Why?
| | Tandem Repeat Sequences | 1 | 2010 | 18 | 0.090 |
Why?
| | Crystallography | 1 | 2010 | 26 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1205 | 0.090 |
Why?
| | NF-kappa B | 1 | 2014 | 653 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 539 | 0.090 |
Why?
| | Peptides | 1 | 2014 | 925 | 0.080 |
Why?
| | Amino Acids | 1 | 2012 | 485 | 0.080 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 89 | 0.080 |
Why?
| | Methionine | 1 | 2009 | 158 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3215 | 0.070 |
Why?
| | Photoreceptor Cells | 1 | 2008 | 16 | 0.070 |
Why?
| | Humans | 8 | 2023 | 129650 | 0.070 |
Why?
| | Myristic Acids | 1 | 2007 | 8 | 0.070 |
Why?
| | Molecular Structure | 2 | 2025 | 482 | 0.070 |
Why?
| | DNA | 1 | 2014 | 1401 | 0.070 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 764 | 0.070 |
Why?
| | Chickens | 1 | 2007 | 188 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 428 | 0.070 |
Why?
| | Fatty Acids | 1 | 2010 | 427 | 0.070 |
Why?
| | Skin Neoplasms | 1 | 2013 | 825 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2009 | 811 | 0.060 |
Why?
| | Spectrum Analysis, Raman | 1 | 2005 | 41 | 0.060 |
Why?
| | Stereoisomerism | 1 | 2025 | 99 | 0.060 |
Why?
| | UDPglucose 4-Epimerase | 1 | 2004 | 2 | 0.060 |
Why?
| | Molecular Conformation | 1 | 2005 | 144 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 192 | 0.060 |
Why?
| | Catalysis | 1 | 2005 | 310 | 0.060 |
Why?
| | DNA Primers | 1 | 2005 | 510 | 0.050 |
Why?
| | ATP-Dependent Proteases | 1 | 2002 | 2 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2002 | 68 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2002 | 99 | 0.050 |
Why?
| | Endopeptidases | 1 | 2002 | 87 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 213 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2002 | 63 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2003 | 207 | 0.050 |
Why?
| | Sulfones | 1 | 2002 | 108 | 0.050 |
Why?
| | Protease Inhibitors | 1 | 2002 | 106 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2002 | 148 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2005 | 1033 | 0.050 |
Why?
| | Adenosine Triphosphatases | 1 | 2002 | 161 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 875 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 692 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 15 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 545 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 196 | 0.030 |
Why?
| | Biocatalysis | 1 | 2015 | 68 | 0.030 |
Why?
| | Lipase | 1 | 2015 | 66 | 0.030 |
Why?
| | Bacillus subtilis | 1 | 2015 | 65 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 179 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 361 | 0.030 |
Why?
| | Temperature | 1 | 2017 | 636 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6556 | 0.030 |
Why?
| | Water | 1 | 2016 | 448 | 0.030 |
Why?
| | Animals | 3 | 2009 | 35362 | 0.020 |
Why?
| | Deuterium Exchange Measurement | 1 | 2010 | 29 | 0.020 |
Why?
| | Acylation | 1 | 2010 | 28 | 0.020 |
Why?
| | S-Adenosylmethionine | 1 | 2009 | 55 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2009 | 192 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 448 | 0.020 |
Why?
| | Mice, Nude | 1 | 2009 | 683 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 610 | 0.020 |
Why?
| | Computational Biology | 1 | 2011 | 599 | 0.020 |
Why?
| | Software | 1 | 2011 | 608 | 0.020 |
Why?
| | Eye Proteins | 1 | 2003 | 88 | 0.010 |
Why?
| | Proteomics | 1 | 2009 | 1062 | 0.010 |
Why?
| | Signal Transduction | 1 | 2009 | 4925 | 0.010 |
Why?
| | Mice | 1 | 2009 | 16937 | 0.010 |
Why?
| | Female | 1 | 2009 | 68776 | 0.000 |
Why?
|
|
Sousa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|